Janux Therapeutics (JANX) Change in Account Payables (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly Change in Account Payables of -$1.6 million for Q1 2026, up 1.53% year-over-year from -$1.6 million in Q1 2025, and down 196.58% quarter-over-quarter from $1.7 million in Q4 2025.
Powered by 
Analysis
Janux Therapeutics (JANX) Change in Account Payables (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Change in Account Payables for 7 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 1.53% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at $1.0 million (up 148.64% YoY), while the FY2025 annual figure was $977000.0, down 38.32% from the prior year.
- Change in Account Payables slipped to -$1.6 million in Q1 2026 per JANX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.7 million in Q4 2025 and bottomed at -$1.6 million in Q1 2025.
- Historically, Change in Account Payables has averaged $54823.5 across 5 years, with a median of -$107000.0 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 415.35% in 2024 and fell as far as 326.17% in 2024.
- Janux Therapeutics' Change in Account Payables stood at $223000.0 in 2022, then jumped by 46.64% to $327000.0 in 2023, then surged by 376.76% to $1.6 million in 2024, then advanced by 7.06% to $1.7 million in 2025, then slumped by 196.58% to -$1.6 million in 2026.
- Business Quant data shows JANX's Change in Account Payables at -$1.6 million in Q1 2026, $1.7 million in Q4 2025, and -$168000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Janux Therapeutics | 1.27 Bn | 1.27 Bn | - | -342,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -342,000.00 |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | -168,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | -694,000.00 |
| Mar 31, 2024 | -456,000.00 |
| Dec 31, 2023 | 327,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Jun 30, 2023 | -171,000.00 |
| Mar 31, 2023 | -107,000.00 |
| Dec 31, 2022 | 223,000.00 |
| Sep 30, 2022 | -634,000.00 |
| Jun 30, 2022 | 857,000.00 |
| Mar 31, 2022 | -740,000.00 |
| Dec 31, 2021 | -482,000.00 |
| Sep 30, 2021 | 2.58 Mn |